Skip to main content
. 2021 Jun 30;16(6):e0251810. doi: 10.1371/journal.pone.0251810

Table 4. Resistance profiles of the different Enterobacteriaceae isolated on admission and during hospitalization.

Enterobacteriaceae species (No.; %) n = 313 No. (%) of resistant isolates at admission
AMX AMC FOX CTX/CAZ GN AK NA NOR/CIP SXT ETP
E. coli (n = 152; 48) 88 65 36 56 51 2 53 46 38 18
K. pneumoniae (n = 124; 39.6) 124 80 3 79 72 0 39 39 49 17
E. cloacae (n = 11; 3.5) * * * 9 7 0 7 5 6 4
K. oxytoca (n = 10; 3.1) 1 1 0 1 1 0 1 1 1 1
C. freundii (n = 5; 1.5) * * * 3 2 1 2 2 1 0
P. mirabilis (n = 5; 1.5) 1 1 1 1 0 0 0 0 0 0
M. morganii (n = 2; 0.6) * * * 0 0 0 0 0 0 0
C. braakii (n = 1; 0.3) 1 1 1 0 0 0 0 0 0 0
P. vulgaris (n = 1; 0.3) * 1 1 0 0 0 0 0 0 0
P. stuartii (n = 1; 0.3) * * * 0 0 0 0 0 0 0
S. marcescens (n = 1; 0.3) * * * 0 0 0 0 0 0 0
Enterobacteriaceae species (No.; %) n = 313 236 (75.3) 169 (53.9) 62 (19.8) 149 (47.6) 133 (42.4) 3 (0.9) 102 (32.5) 93 (29.7) 95 (30.3) 40 (12.7)
No. (%) of resistant isolates during NICU stay
AMX AMC FOX CTX/ CAZ GN AK NA NOR/CIP SXT ETP
K. pneumoniae (n = 195; 59.4) 195 184 10 184 169 0 95 90 99 18
E. coli (n = 109; 33.2) 100 96 63 93 89 9 79 77 28 26
E. cloacae (n = 6; 1.8) * * * 6 3 1 3 3 3 2
K. oxytoca (n = 6; 1.8) * 5 1 5 5 0 2 2 3 2
C. freundii (n = 5; 1.5) * * * 4 3 0 1 1 0 1
p. mirabilis (n = 4; 1.2) 4 3 0 2 2 0 2 0 0 0
M. morganii (n = 2; 0.6) * * * 1 1 0 0 0 0 0
E. aerogenes (n = 1; 0.3) * * * 0 0 0 0 0 0 0
Enterobacteriaceae species (No.; %) n = 328 319 (97.2) 302 (92) 88 (26.8) 295 (89.9) 272 (82.9) 10 (3) 182 (55.4) 173 (52.7) 133 (40.5) 49 (14.9)

*Natural resistance

AMP: ampicillin; AMC: amoxicillin / clavulanic acid; FOX: cefoxitin; CTX: cefotaxim; CAZ: ceftazidim; GN: gentamicin; AK: amikacin; NA: nalidixic acid; NOR: norfloxacin; CIP: ciprofloxacin, SXT: cotrimoxazol; ETP: ertapenem.